ALLARITY THERAPEUTICS, INC.
Income flow
Annual
ALLR 10-K Income StatementPeriod 2025-12-31Source 10-K
As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.
Revenue mix
2025-12-31 · 10-K · USD
By activity
- License$320,000100.0%
Capital & dividends
YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).15.9MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).15.8M
Shares outstanding (as-filed)
7.3M24
16.1M25
Stock splits
- 1:302024-09-11
- 1:202024-04-09
- 1:402023-06-29
- 1:352023-03-27